The Prescription Drug Playbook, Part II
In this second part of a two-part series on dealing with the high price of prescription drugs, experts share their insider tips.
Drug Costs
21 - 40 of 686 Results
The Prescription Drug Playbook, Part I
Season 13, Episode 9In Part 1 of a two-part series on dealing with the high price of prescription drugs, a father explains the strategies he used to get his daughter the medicine she needs to treat her epilepsy.
-
Trump Exaggerates Speed and Certainty of Prescription Drug Price Reductions
According to the timeline in the May 12 executive order, prescription drug price reductions would not happen "almost immediately, but rather could take months or years. And extending the savings to Americans outside federal health insurance programs such as Medicare would likely require congressional action.
-
Journalists Unpack Drug Prices, Threats to Medicaid, and the Fluoridation of Water
窪蹋勛圖厙 News journalists made the rounds on national and local media recently to discuss topical stories. Heres a collection of their appearances.
-
Pharmacists Stockpile Most Common Drugs on Chance of Targeted Trump Tariffs
While Big Pharma seems ready to weather the tariff storm, independent pharmacists and makers of generic drugs which account for 90% of U.S. prescriptions see trouble ahead for patients.
By Jackie Forti矇r and Arthur Allen GOP Tries To Cut Billions in Health Benefits
Episode 397GOP-controlled House committees approved parts of President Donald Trumps one big, beautiful bill this week, including more than $700 billion in cuts to health programs over the next decade mostly from Medicaid, which covers people with low incomes or disabilities. Meanwhile, Health and Human Services Secretary Robert F. Kennedy Jr. testified before Congress for the first time since taking office and told lawmakers that Americans shouldnt take medical advice from him. Julie Appleby of 窪蹋勛圖厙 News, Alice Miranda Ollstein of Politico, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico Magazine join 窪蹋勛圖厙 News Julie Rovner to discuss these stories and more.
Cutting Medicaid Is Hard Even for the GOP
Episode 396Republicans on Capitol Hill are struggling to reach consensus on cutting the Medicaid program as they search for nearly a trillion dollars in savings over the next decade as many observers predicted. Meanwhile, turmoil continues at the Department of Health and Human Services, with more controversial cuts and personnel moves, including the sudden nomination of Casey Means, an ally of Robert F. Kennedy Jr.s, to become surgeon general. Anna Edney of Bloomberg News, Maya Goldman of Axios, and Sandhya Raman of CQ Roll Call join 窪蹋勛圖厙 News Julie Rovner to discuss these stories and more. Also this week, Rovner interviews 窪蹋勛圖厙 News Lauren Sausser, who co-reported the latest Bill of the Month feature, about an unexpected bill for what seemed like preventive care.
On Autism, Its the Secretarys Word vs. the CDCs
Episode 393Tensions between Robert F. Kennedy Jr. and his employees at the Department of Health and Human Services are mounting, as he made a series of claims about autism this week contradicting his agencys findings. Plus, President Donald Trump unveiled an executive order to lower drug prices as his administration explores tariffs that could raise them. Shefali Luthra of The 19th, Jessie Hellmann of CQ Roll Call, and Anna Edney of Bloomberg News join 窪蹋勛圖厙 News Emmarie Huetteman to discuss these stories and more. Plus, 窪蹋勛圖厙 News Julie Rovner interviews two University of California-San Francisco researchers about an upcoming Supreme Court case that could have major ramifications for preventive care.
American Health Gets a Pink Slip
Episode 391The Department of Health and Human Services underwent an unprecedented purge this week, as thousands of employees from the National Institutes of Health, the FDA, the Centers for Disease Control and Prevention, and other agencies were fired, placed on administrative leave, or offered transfers to far-flung Indian Health Service facilities. Altogether, the layoffs mean the federal government, in a single day, shed hundreds if not thousands of combined years of health and science expertise. Lauren Weber of The Washington Post, Rachel Cohrs Zhang of Bloomberg News, and Sarah Karlin-Smith of the Pink Sheet join 窪蹋勛圖厙 News Julie Rovner to discuss this enormous breaking story and more. Also this week, Rovner interviews 窪蹋勛圖厙 News Julie Appleby, who reported and wrote the latest Bill of the Month feature about a short-term health plan and a very expensive colonoscopy.
-
Montanas Small Pharmacies Behind Bill To Corral Pharmacy Benefit Managers
A bill designed to force PBMs to pay higher fees to independent drugstores sailed through the state House, but lobbyists are marshaling their forces to kill the measure in the Senate.
Federal Health Work in Flux
Episode 389Its the Trump administration vs. the federal courts, as the Department of Government Efficiency continues to try to cancel federal contracts and programs and fire workers. But in the haste to cut things, jobs and programs are being eliminated even if they align with the new administrations goal to Make America Healthy Again. Jessie Hellmann of CQ Roll Call, Sarah Karlin-Smith of the Pink Sheet, and Rachel Roubein of The Washington Post join 窪蹋勛圖厙 News Julie Rovner to discuss these stories and more.
-
Years Later, Centene Settlements With States Still Unfinished
At least 20 states have settled disputes with health insurance giant Centene since 2021 over allegations that its pharmacy benefit manager operation overcharged their Medicaid programs. Two holdouts appear to remain: Georgia has not yet settled, and Florida officials wont answer questions about its Centene situation.
By Andy Miller -
Republicans Once Wanted Government out of Health Care. Trump Voters See It Differently.
Frustrated by high health care prices, many who backed President Donald Trump support strong government actions to protect patients. Its unclear whether GOP leaders will listen.
-
Top California Democrats Clash Over How To Rein In Drug Industry Middlemen
Frustrated by spiraling drug costs, California lawmakers want to increase oversight of pharmaceutical industry intermediaries known as pharmacy benefit managers. Its unclear whether they can persuade Gov. Gavin Newsom to get on board.
How Do You Deal With Wild Drug Prices?
Season 13, Episode 2An Arm and a Leg is collecting stories for a new series about how Americans get the medicine they need when faced with sticker shock.
-
What To Know About Trumps Executive Orders on US Health Care
From rolling back drug pricing policies to limiting gender-affirming care, President Donald Trump signed several health-related executive orders in the first hours of his second presidency. Heres a roundup of the changes and what they mean.
Hello, Trump. Bye-Bye, Biden.
Episode 380With just days to go before the official launch of a new administration, the GOP-led Congress is putting together plans on how to enact incoming President Donald Trumps agenda, with a particular emphasis on cutting spending on the Medicaid program. Meanwhile, the Biden administration makes major moves in its last days, including banning a controversial food dye and ordering cigarette companies to minimize their nicotine content. Joanne Kenen of Johns Hopkins University and Politico Magazine, Anna Edney of Bloomberg News, and Sandhya Raman of CQ Roll Call join 窪蹋勛圖厙 News Julie Rovner to discuss these stories and more. Also this week, Rovner interviews Harris Meyer, who reported and wrote the latest 窪蹋勛圖厙 News Bill of the Month feature, about a colonoscopy that came with a much larger price tag than estimated.
-
Health Care Is Newsoms Biggest Unfinished Project. Trump Complicates That Task.
As Gov. Gavin Newsom enters the second half of his final term, health care stands out as his most ambitious but glaringly incomplete initiative for California residents. The issue will likely shape his national profile for better or worse. And now, Donald Trump brings a new wrinkle.
By Angela Hart and Christine Mai-Duc -
How a Duty To Spend Wisely on Worker Benefits Could Loosen PBMs Grip on Drug Prices
As criticism of pharmacy benefit managers heats up, fear of lawsuits is driving some big employers to drop the Big Three PBMs or force them to change.
By Arthur Allen -
Readers Embrace ‘Going It Alone’ Series on Aging and Chastise Makers of Pulse Oximeters
窪蹋勛圖厙 News gives readers a chance to comment on a recent batch of stories.